| 1 |
33974997 |
10.1016/j.ymthe.2021.05.006 |
2022 |
Self-driving armored CAR-T cells overcome a suppressive milieu and eradicate CD19<sup>+</sup> Raji lymphoma in preclinical models. |
TGFBR2 |
| 2 |
35062067 |
10.1016/j.biopha.2021.112601 |
2022 |
Genistein alleviates renin-angiotensin system mediated vascular and kidney alterations in renovascular hypertensive rats. |
TGFBR2 |
| 3 |
35774514 |
10.3389/fgene.2022.827840 |
2022 |
A Novel Defined Super-Enhancer Associated Gene Signature to Predict Prognosis in Patients With Diffuse Large B-Cell Lymphoma. |
TGFBR2 |
| 4 |
32838054 |
10.1016/j.coemr.2020.07.011 |
2021 |
Subcellular hot spots of GPCR signaling promote vascular inflammation. |
TGFBR2 |
| 5 |
33024088 |
10.1038/s41408-020-00365-4 |
2021 |
Single-nucleotide variants in TGFB1, TGFBR2, IL17A, and IL17F immune response genes contribute to follicular lymphoma susceptibility and aggressiveness. |
TGFBR2 |
| 6 |
33648463 |
10.1186/s12885-021-07891-9 |
2021 |
Single nucleotide variants in immune-response genes and the tumor microenvironment composition predict progression of mantle cell lymphoma. |
TGFBR2 |
| 7 |
33652176 |
10.1016/j.jss.2020.10.034 |
2021 |
Blocking SNHG14 Antagonizes Lipopolysaccharides-Induced Acute Lung Injury via SNHG14/miR-124-3p Axis. |
TGFBR2 |
| 8 |
30880689 |
10.4103/aja.aja_8_19 |
2020 |
Losartan improves erectile function through suppression of corporal apoptosis and oxidative stress in rats with cavernous nerve injury. |
TGFBR2 |
| 9 |
32913559 |
10.18632/oncotarget.27698 |
2020 |
An integrative microenvironment approach for follicular lymphoma: roles of inflammatory cell subsets and immune-response polymorphisms on disease clinical course. |
TGFBR2 |
| 10 |
29315015 |
10.1200/JCO.2017.74.3179 |
2019 |
Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma. |
TGFBR2 |
| 11 |
29615404 |
10.1182/blood-2017-10-810630 |
2019 |
The tumor suppressive TGF-β/SMAD1/S1PR2 signaling axis is recurrently inactivated in diffuse large B-cell lymphoma. |
TGFBR2 |
| 12 |
28055980 |
10.18632/oncotarget.14410 |
2018 |
Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker. |
TGFBR2 |
| 13 |
28466233 |
10.1007/s10815-017-0930-6 |
2018 |
Age-related expression of TGF beta family receptors in human cumulus oophorus cells. |
TGFBR2 |
| 14 |
28281962 |
10.3727/096504016X14685034103473 |
2017 |
MicroRNA-155 Downregulation Promotes Cell Cycle Arrest and Apoptosis in Diffuse Large B-Cell Lymphoma. |
TGFBR2 |
| 15 |
25791160 |
10.5301/jbm.5000134 |
2016 |
Identification of biomarkers for the prognosis of pancreatic ductal adenocarcinoma with miRNA microarray data. |
TGFBR2 |
| 16 |
26168957 |
10.1007/s13277-015-3700-z |
2016 |
Transforming growth factor β type II receptor as a marker in diffuse large B cell lymphoma. |
TGFBR2 |
| 17 |
26632380 |
10.3349/ymj.2016.57.1.33 |
2016 |
Anti-Proliferative and Apoptotic Activities of Müllerian Inhibiting Substance Combined with Calcitriol in Ovarian Cancer Cell Lines. |
TGFBR2 |
| 18 |
25338019 |
10.18632/oncotarget.2463 |
2015 |
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity. |
TGFBR2 |
| 19 |
25716962 |
|
2015 |
Analysis of microRNA expression in canine mammary cancer stem-like cells indicates epigenetic regulation of transforming growth factor-beta signaling. |
TGFBR2 |
| 20 |
23827971 |
10.1016/j.pneurobio.2013.06.002 |
2014 |
Impaired autophagy and APP processing in Alzheimer's disease: The potential role of Beclin 1 interactome. |
TGFBR2 |
| 21 |
23830891 |
10.1016/j.biocel.2013.06.018 |
2014 |
Activin receptor-like kinase 7 mediates high glucose-induced H9c2 cardiomyoblast apoptosis through activation of Smad2/3. |
TGFBR2 |
| 22 |
22915806 |
10.1128/JVI.06855-11 |
2013 |
A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival. |
TGFBR2 |
| 23 |
23167606 |
10.3109/10428194.2012.751529 |
2013 |
Regulation of expression of ABCB1 and LRP genes by mitogen-activated protein kinase/extracellular signal-regulated kinase pathway and its role in generation of side population cells in canine lymphoma cell lines. |
TGFBR2 |
| 24 |
23246696 |
10.1016/j.gene.2012.12.009 |
2013 |
Regulation of the MIR155 host gene in physiological and pathological processes. |
TGFBR2 |
| 25 |
23290524 |
10.1016/j.molcel.2012.12.002 |
2013 |
c-Cbl-mediated neddylation antagonizes ubiquitination and degradation of the TGF-β type II receptor. |
TGFBR2 |
| 26 |
22013049 |
10.1128/JVI.06245-11 |
2012 |
Kaposi's sarcoma-associated herpesvirus-encoded microRNA miR-K12-11 attenuates transforming growth factor beta signaling through suppression of SMAD5. |
TGFBR2 |
| 27 |
21131601 |
10.1158/1541-7786.MCR-10-0216 |
2011 |
Distinctive mechanism for sustained TGF-β signaling and growth inhibition: MEK1 activation-dependent stabilization of type II TGF-β receptors. |
TGFBR2 |
| 28 |
21412408 |
10.1371/journal.pone.0014758 |
2011 |
Effect of Xpcl1 activation and p27(Kip1) loss on gene expression in murine lymphoma. |
TGFBR2 |
| 29 |
20233627 |
10.1016/j.leukres.2010.02.017 |
2010 |
Mismatch repair and the downstream target genes, PAX5 and Ikaros, in childhood acute lymphoblastic leukemia. |
TGFBR2 |
| 30 |
19229971 |
10.1002/pbc.21971 |
2009 |
A case-control study of childhood acute lymphoblastic leukaemia and polymorphisms in the TGF-beta and receptor genes. |
TGFBR2 |
| 31 |
18199825 |
10.1182/blood-2007-09-110544 |
2008 |
KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. |
TGFBR2 |
| 32 |
18310898 |
10.1248/bpb.31.391 |
2008 |
Treatment of Ewing's sarcoma using an antisense oligodeoxynucleotide to regulate the cell cycle. |
TGFBR2 |
| 33 |
18463534 |
10.1097/CJI.0b013e318177092b |
2008 |
Antitumor activity of EBV-specific T lymphocytes transduced with a dominant negative TGF-beta receptor. |
TGFBR2 |
| 34 |
16638184 |
|
2007 |
[Identification of the isoform in type II receptor of transforming growth factor-beta in patients with acute leukemia and its clinical significance]. |
TGFBR2 |
| 35 |
17339425 |
10.1182/blood-2006-06-032128 |
2007 |
Resistance to TGF-beta 1 correlates with aberrant expression of TGF-beta receptor II in human B-cell lymphoma cell lines. |
TGFBR2 |
| 36 |
16699368 |
10.1097/01.cji.0000192104.24583.ca |
2006 |
Assessing the safety of cytotoxic T lymphocytes transduced with a dominant negative transforming growth factor-beta receptor. |
TGFBR2 |
| 37 |
16998876 |
10.1002/jmv.20719 |
2006 |
Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation. |
TGFBR2 |
| 38 |
14704634 |
|
2004 |
Expression of TGF beta1 genes and their receptor types I, II, and III in low- and high-grade malignancy non-Hodgkin's lymphomas. |
TGFBR2 |
| 39 |
14747535 |
10.1128/jvi.78.4.1697-1705.2004 |
2004 |
Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway. |
TGFBR2 |
| 40 |
15109545 |
10.1016/j.leukres.2003.07.006 |
2004 |
Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5. |
TGFBR2 |
| 41 |
15295044 |
10.1056/NEJMp048121 |
2004 |
TGF-beta signaling, tumor suppression, and acute lymphoblastic leukemia. |
TGFBR2 |
| 42 |
15374963 |
10.1158/0008-5472.CAN-04-0896 |
2004 |
Transforming growth factor-beta pathway serves as a primary tumor suppressor in CD8+ T cell tumorigenesis. |
TGFBR2 |
| 43 |
15470494 |
10.1038/sj.leu.2403485 |
2004 |
TGFbeta-mediated activation of Smad1 in B-cell non-Hodgkin's lymphoma and effect on cell proliferation. |
TGFBR2 |
| 44 |
12458885 |
|
2003 |
The Reed-Steinberg cell: molecular characterization by proteomic analysis with therapeutic implications. |
TGFBR2 |
| 45 |
12479849 |
10.1016/s0145-2126(02)00078-4 |
2003 |
Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation. |
TGFBR2 |
| 46 |
12546068 |
|
2003 |
Diminished expression of the type II receptor for TGFbeta (TGFbetaRII) in T lymphocytes from patients with Sezary syndrome is not due to mutations in the receptor's poly-A tract: limitations of the standard RT-PCR in cDNA sequence analysis of homopolymeric base stretches. |
TGFBR2 |
| 47 |
11911400 |
10.3109/10428190109097744 |
2002 |
CD105 (endoglin) expression on hematopoietic stem/progenitor cells. |
TGFBR2 |
| 48 |
11964281 |
10.1182/blood.v99.9.3179 |
2002 |
Adapting a transforming growth factor beta-related tumor protection strategy to enhance antitumor immunity. |
TGFBR2 |
| 49 |
11483955 |
10.1038/35087019 |
2001 |
TGF-beta-induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation. |
TGFBR2 |
| 50 |
11594580 |
10.1111/j.1749-6632.2001.tb03708.x |
2001 |
Crosstalk between tumor T lymphocytes and reactive T lymphocytes in cutaneous T cell lymphomas. |
TGFBR2 |
| 51 |
10666234 |
|
2000 |
Mutations of the E2F4 gene in hematological malignancies having microsatellite instability. |
TGFBR2 |
| 52 |
10688836 |
|
2000 |
MSH2-deficient murine lymphomas harbor insertion/deletion mutations in the transforming growth factor beta receptor type 2 gene and display low not high frequency microsatellite instability. |
TGFBR2 |
| 53 |
10811940 |
10.1099/0022-1317-81-6-1567 |
2000 |
Resistance to TGF-beta1 correlates with a reduction of TGF-beta type II receptor expression in Burkitt's lymphoma and Epstein-Barr virus-transformed B lymphoblastoid cell lines. |
TGFBR2 |
| 54 |
10886511 |
10.1046/j.1523-1747.2000.00995.x |
2000 |
Cutaneous T cell lymphoma reactive CD4+ cytotoxic T lymphocyte clones display a Th1 cytokine profile and use a fas-independent pathway for specific tumor cell lysis. |
TGFBR2 |
| 55 |
10960763 |
10.1016/s0304-3835(00)00512-7 |
2000 |
Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma. |
TGFBR2 |
| 56 |
10555111 |
10.1089/088922299309991 |
1999 |
Transforming growth factor beta is a growth-inhibitory cytokine of B cell lymphoma in SIV-infected macaques. |
TGFBR2 |
| 57 |
9589477 |
10.1111/j.1440-1827.1998.tb03882.x |
1998 |
Transforming growth factor beta type II receptor (TGF beta RII) mutation in gastric lymphoma without mutator phenotype. |
TGFBR2 |
| 58 |
8993839 |
|
1997 |
Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells. |
TGFBR2 |
| 59 |
9071813 |
10.1016/s0925-5710(96)00542-7 |
1997 |
TGF-beta receptors and signal transduction. |
TGFBR2 |
| 60 |
8543807 |
|
1996 |
Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells. |
TGFBR2 |
| 61 |
8668164 |
10.1128/MCB.16.7.3480 |
1996 |
A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. |
TGFBR2 |
| 62 |
7669719 |
|
1995 |
Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta. |
TGFBR2 |
| 63 |
7777538 |
10.1073/pnas.92.12.5501 |
1995 |
Reduced surface expression of transforming growth factor beta receptor type II in mitogen-activated T cells from Sézary patients. |
TGFBR2 |
| 64 |
8016105 |
10.1073/pnas.91.13.6002 |
1994 |
Loss of receptors for transforming growth factor beta in human T-cell malignancies. |
TGFBR2 |
Datasets
Models
